WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Web Hosting Computer Hardware Thursday, May 25, 2017 
Add Press Release News | News Feeds Feeds | Email This News Email

H1 Eosinophilic Esophagitis Pipeline Outlook of Market Companies and Drug Profile in Gastrointestinal Report 2017
Friday, May 19, 2017

The Eosinophilic Esophagitis - Pipeline Review, H1 2017 report covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II and Preclinical stages are 2, 4 and 4 respectively.

PUNE, India, May 19, 2017 /PRNewswire-iReach/ -- Eosinophilic Esophagitis - Pipeline Review, H1 2017 is new research report added on The Eosinophilic Esophagitis (Gastrointestinal) market pipeline guide also reviews of key players involved in therapeutic development for Eosinophilic Esophagitis and features dormant and discontinued projects.

Browse the 16 Tables and 10 Figures, 40 Company Profiles, Spread across 148 Pages Report Available at

Eosinophilic Esophagitis market companies - Adare Pharmaceuticals Inc, Calypso Biotech SA, Celgene Corp, DBV Technologies SA, Dr. Falk Pharma GmbH, Quorum Innovations LLC, Regeneron Pharmaceuticals Inc, Shire Plc.

Eosinophilic Esophagitis - Drug Profiles: Eosinophilic Esophagitis, Allergen for Milk Allergy, BPRX-060216, budesonide, budesonide, CALY-002, dupilumab, fluticasone propionate, fluticasone propionate.

Eosinophilic esophagitis is disease characterized by the presence of a large number of a special type of white blood cell, the eosinophil that can cause inflammation in the esophagus. Symptoms include poor weight gain, abdominal pain, nausea, and vomiting, coughing, heartburn and chest pain. Risk factors include weakened immune system, chemotherapy, aspirin and anti-inflammatory medications, chronic vomiting, obesity and alcohol and cigarette use. Treatment includes antiviral, antifungal and pain relievers.

Order a Copy of Report at

Pharmaceutical and Healthcare latest pipeline guide Eosinophilic Esophagitis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Eosinophilic Esophagitis (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Eosinophilic Esophagitis (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Discount Available at

List of Tables
Number of Products under Development for Eosinophilic Esophagitis, H1 2017
Number of Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Eosinophilic Esophagitis - Pipeline by Adare Pharmaceuticals Inc, H1 2017
Eosinophilic Esophagitis - Pipeline by Calypso Biotech SA, H1 2017
Eosinophilic Esophagitis - Pipeline by Celgene Corp, H1 2017
Eosinophilic Esophagitis - Pipeline by DBV Technologies SA, H1 2017
Eosinophilic Esophagitis - Pipeline by Dr. Falk Pharma GmbH, H1 2017
Eosinophilic Esophagitis - Pipeline by Quorum Innovations LLC, H1 2017
Eosinophilic Esophagitis - Pipeline by Regeneron Pharmaceuticals Inc, H1 2017
Eosinophilic Esophagitis - Pipeline by Shire Plc, H1 2017
Eosinophilic Esophagitis - Dormant Projects, H1 2017

Related New Reports:

Gastroenteritis - Pipeline Review, H1 2017

Ulcerative Colitis - Pipeline Review, H1 2017

Enterocolitis - Pipeline Review, H1 2017

Explore Other Reports on Pharmaceuticals Market at

About Us: is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details at This e-mail address is being protected from spambots. You need JavaScript enabled to view it and we would be happy to help you find the business intelligence that you need. offers research studies on agriculture, energy and power, automotive, Semiconductor and Electronics, Manufacturing & Construction, chemicals, environment, medical devices, healthcare, food and beverages, water and much more.

Media Contact: Ritesh Tiwari, ReportsnReports, + 1 888 391 5441,

News distributed by PR Newswire iReach:


Email This News Email | Submit To Slashdot Slashdot | Submit To Digg | Submit To | News Feeds Feeds

Nav Commvault calls on businesses to accelerate GDPR compliance preparations | May 24, 2017
Nav u-blox, Commsignia and NXP Collaborate to Drive V2X | May 24, 2017
Nav Barracuda Releases Free Public Cloud Network and Application Security Solutions for AWS and Azure to Help Accelerate Cloud Migrations | May 24, 2017
Nav enSilo Protects Millions of Unsupported Windows XP and Windows Server 2003 Users from Future Malware Attacks with Independent Patch for "ESTEEMAUDIT" RDP Exploit | May 24, 2017
Nav AgigA Tech Granted Patent for Hybrid Non-Volatile RAM in China | May 24, 2017
Nav CTIntegrations Welcomes Paula E. Morton as Vice President of Channel Sales | May 24, 2017
Nav Altair Provides 4G LTE Connectivity to New Wireless Home Phone from Verizon | May 24, 2017
Nav Crossmatch Selected by Northrop Grumman for Livescan Enrollment Station Upgrade Across UK | May 24, 2017
Nav Raytheon completes modernization of the Nation's busiest Air Traffic Control facility ahead of schedule | May 24, 2017
Nav As Global Research and Development Network Expands, Vivo Smartphone Shipments Remain Among Top 5 Worldwide Per IDC Report | May 24, 2017

Submit News | View More News View More News